2,606
Views
78
CrossRef citations to date
0
Altmetric
Author's View

HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families

, , , &
Article: e1026534 | Received 27 Feb 2015, Accepted 27 Feb 2015, Published online: 30 Jun 2015

Figures & data

Figure 1. The B7 and CD28 families and the significance of HHLA2 and TMIGD2 within the tumor microenvironment. (A) A structural representation of the B7 and CD28 family members. (B) A proposed model for the roles of HHLA2 and TMIGD2 within the tumor microenvironment. Tumor-expressed HHLA2 can interact not only with an unidentified receptor on activated T cells that leads to coinhibition, but also with TMIGD2 on endothelium that stimulates tumor angiogenesis. Additionally, tumor-expressed HHLA2 can bind to other immune cells and likely affects their functions in ways that are not yet understood. Finally, tumor-associated macrophages (TAM) may express HHLA2 and interact with TMIGD2 on endothelium.

Figure 1. The B7 and CD28 families and the significance of HHLA2 and TMIGD2 within the tumor microenvironment. (A) A structural representation of the B7 and CD28 family members. (B) A proposed model for the roles of HHLA2 and TMIGD2 within the tumor microenvironment. Tumor-expressed HHLA2 can interact not only with an unidentified receptor on activated T cells that leads to coinhibition, but also with TMIGD2 on endothelium that stimulates tumor angiogenesis. Additionally, tumor-expressed HHLA2 can bind to other immune cells and likely affects their functions in ways that are not yet understood. Finally, tumor-associated macrophages (TAM) may express HHLA2 and interact with TMIGD2 on endothelium.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.